Refresh Can’t Get Enough of London! 🇬🇧


As the third pillar of the ‘golden triangle’, London is undoubtedly one of the biggest hubs for biotech companies in Europe. In recent years, this city has seen big acquisitions of biotech companies such as Nightstar Therapeutics or Heptares. With cash flowing into this city’s life sciences scene, many companies in London are at the forefront of innovation. Following the successful event last year, we are excited to come back to London with this year’s ‘last but not least’ Refresh edition!

This time we will invite 80 of our readers to join us. Members of our Insider Program will get a priority spot that allows you to meet biotech professionals, get inspired by amazing talks, and enjoy a relaxing evening with free beers and a friendly networking vibe. If you wish to attend, join our membership now to get a priority ticket. If you’re not yet a member, please confirm your participation by filling out this form. We will inform you about your registration status few days before the event.

A big thank you to our co-host Stanhope as well as our sponsors NIBC and JLABS for their generous support. 😉





A special thanks to One Nucleus for helping out! Make sure to check out their event Genesis that is taking place in the next day.

When and where is it?

This meetup will take place on December 10th, 2019 at White City Place (201 Wood Ln, White City, London W12 7FQ, United Kingdom).


What’s on the program?

Theme of the meetup: New Technologies Building the Future of Biotech

06:30pm – 07:00pm: Door open & Welcome
07:00pm – 07:10pm: Intro by Labiotech & Stanhope
07:10pm – 07:40pm: 1st Fireside chat with Mike Romanos, Co-founder and CEO of Microbiotica 
07:40pm – 08:10pm: 2nd Fireside chat with Paolo Paoletti, CEO of GammaDelta Therapeutics
08:10pm – 08:15pm: Closing remark
08:15pm – 10:00pm: Enjoy beers, snacks, and networking


Mike Romanos, Co-founder and CEO of Microbiotica 

Mike Romanos has 30 years’ experience in the biotech and pharma industry and previously co-founded Crescendo Biologics which he built and led as CEO and CSO. Prior to that he held global VP roles in GSK R&D for over 10 years. In his last role he led a trans-national group of 300 staff providing genomics, target and biomarker discovery, and platform biology for R&D. Romanos is highly experienced in the biotech translation and commercialisation, currently serving as a Non-Exec Director of the life-sciences charity LifeArc, and previously as Translational Adviser in Biomedicine at Imperial College, Venture Partner to UK Innovation and Science Seed Fund, as well as a committee member on the MRC’s Developmental Pathway Funding Scheme for translational academic research.

Romanos’ academic work included research in influenza virology and in yeast genetics and biotechnology. He holds a degree in Natural Sciences from Cambridge University, a PhD in Molecular Virology from Imperial College, and is a Fellow of the Royal Society of Biology.


Paolo Paoletti, CEO of GammaDelta Therapeutics

Paolo Paoletti was the first appointed president of GSK Oncology where he was responsible for championing an organisation of more than 2,000 professionals around the world dedicated to fighting cancer. During his tenure at GSK, seven new cancer treatments were approved globally, generating annual sales of about US$2 billion. Prior to GSK, Paoletti was Vice President of Oncology Clinical Research at Eli Lilly, where he developed ALIMTA® , a chemotherapy drug for non-small cell lung cancer. Most recently he was the CEO of Kesios Therapeutics. He now serves on the Boards of companies such as Genmab, PsiOxus Therapeutics, FORMA Therapeutics and Nucana Biomed.

Paoletti has a degree in Medicine from the University of Pisa where he was professor in Pulmonary Diseases and authored more than 300 publications.


How can I join?

For Insider Members
If you are a member, simply fill out the form to get a priority spot. 

For Non-Members

  • Join Labiotech Insider Program now to get a ticket as a member by filling out this form (the membership also includes other benefits).
  • If you are not sure whether you want to become a member now or not, it’s totally fine. Please fill out this form so we can put your name on the waiting list. If there are still tickets available, they will be given out to people on the list on a first come first served basis. We will inform you about your registration status few days before the event.



❗️Members who join before December 31st, 2019 will get 2 months for free. Your membership also includes access to all of the future events and many more perks! Read more here.❗️


What to expect?

  • Relaxed biotech event
  • 2 fireside chats with awesome speakers
  • Networking opportunities with the biotechnologists in your area
  • 80 attendees
  • Free beers and snacks
  • The unique Refresh vibe


Remember to leave your tie/blazers at home so you can chill out and be a biotech nerd in comfort.


Check out what happened in Paris:

What happens if I miss out on this Refresh?

See what we’re up to next by subscribing to our lovely newsletter. 😊

If you have any questions then feel free to send me a message at

Support good journalism, subscribe to Labiotech Insider

Labiotech Insider

If you liked this post and want to read more good journalism, support us by joining Labiotech Insider. Our Insider membership gives you access to exclusive content and other advantages.